30.06.2014
- The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...
02.06.2014
- Danish drugmaker Novo Nordisk, the world's biggest insulin producer, has decided to launch its diabetes drug Tresiba in Germany after seeing signs of a more favorable pricing...
29.05.2014
- US drugmaker Eli Lilly has struck a licensing deal with Sanofi that would allow its French rival to pursue regulatory approval for a non-prescription version of Lilly's erectile...
05.05.2014
- Volatility Calls For Flexibility - Supply-chain management (SCM) requirements have changed significantly over the past few years. The buzzword when managing global supply chains is...
23.04.2014
- The book "LEAN Supply Chain Planning - The New Supply Chain Management Paradigm for Process Industries to Master Today's VUCA World" introduces a new and innovative approach to...
23.04.2014
- "It is not about improving the accuracy of the forecast and reducing the amount of uncertainty in the future, it is about eliminating the need for certainty." Ronald W. Bohl...
23.04.2014
- In one of several deals announced just after Easter, Swiss drugmaker Novartis said it would sell its animal health arm to U.S. rival Eli Lilly for about $5.4 billion. Lilly said...
23.04.2014
- Novartis and GlaxoSmithKline have announced an asset swap worth more than $20 billion, with an eye to bolstering their best businesses and exiting weaker ones. The swap, which...
